Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Laboratory variability and precise clinical decision making.

Redberg RF.

Arch Intern Med. 2012 Oct 22;172(19):1521. No abstract available.

PMID:
22945553
2.

Role of C-reactive protein in the assessment of cardiovascular risk.

Jialal I, Devaraj S.

Am J Cardiol. 2003 Jan 15;91(2):200-2. Review. No abstract available.

PMID:
12521635
3.

C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.

Blake GJ, Ridker PM.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1512-3. Review. No abstract available.

4.

Prospective studies of C-reactive protein as a risk factor for cardiovascular disease.

Ridker PM, Haughie P.

J Investig Med. 1998 Oct;46(8):391-5. Review. No abstract available.

PMID:
9805425
5.

C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?

Szmitko PE, Verma S.

J Cardiometab Syndr. 2006 Winter;1(1):66-9; quiz 70-1. Review.

6.

[C-reactive protein potential risk factor for cardiovascular disease].

Tornvall P, Pernow J, Hansson LO.

Lakartidningen. 2003 Aug 28;100(35):2691-3. Review. Swedish.

PMID:
14531129
7.
8.

[CRP and cardiovascular prevention in the elderly].

Benoit MO.

Ann Biol Clin (Paris). 2001 Jul-Aug;59(4):469-73. Review. French. No abstract available.

9.

Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?

Genest J.

Can J Cardiol. 2004 Aug;20 Suppl B:89B-92B. Review.

PMID:
15309211
10.

C-reactive protein as a novel biomarker. Reactant can flag atherosclerosis and help predict cardiac events.

Elgharib N, Chi DS, Younis W, Wehbe S, Krishnaswamy G.

Postgrad Med. 2003 Dec;114(6):39-44; quiz 16. Review.

PMID:
14689723
11.

[C-reactive protein and cardiovascular disease. Basis of scientific evidence].

Santos WB, Mesquita ET, Vieira RM, Olej B, Coutinho M, Avezum A.

Arq Bras Cardiol. 2003 Apr;80(4):452-6. Epub 2003 Apr 29. Review. Portuguese. No abstract available.

12.

Role of C-reactive protein when prescribing a statin.

Kinlay S.

Curr Atheroscler Rep. 2012 Feb;14(1):26-32. doi: 10.1007/s11883-011-0218-8. Review.

PMID:
22125118
13.

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.

Battistoni A, Rubattu S, Volpe M.

Int J Cardiol. 2012 May 31;157(2):160-8. doi: 10.1016/j.ijcard.2011.06.066. Epub 2011 Jul 16. Review.

PMID:
21763018
14.

Should we measure C-reactive protein on earth or just on JUPITER?

Bajpai A, Goyal A, Sperling L.

Clin Cardiol. 2010 Apr;33(4):190-8. doi: 10.1002/clc.20681. Review.

15.

Novel serologic markers of cardiovascular risk.

Oliveira GH.

Curr Atheroscler Rep. 2005 Mar;7(2):148-54. Review.

PMID:
15727731
16.

C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.

Maseri A.

Ital Heart J. 2001 Mar;2(3):155-6. Review. No abstract available.

PMID:
11305525
17.

[Emerging risk factors for cardiovascular disease].

Demant T.

Dtsch Med Wochenschr. 2004 Jan 30;129(5):204-9. Review. German. No abstract available.

PMID:
14735418
18.

C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians.

Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL.

Postgrad Med. 2011 Jan;123(1):114-9. doi: 10.3810/pgm.2011.01.2252. Review.

PMID:
21293091

Supplemental Content

Support Center